Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Ann Surg Oncol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502296
3.
Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
J Surg Res
; 295: 705-716, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141457
4.
Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma.
HPB (Oxford)
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705793
5.
Why the Treatment Sequence Matters: Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas Cancer.
Ann Surg
; 278(4): e677-e684, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071769
6.
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
Oncologist
; 28(6): 510-519, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848266
7.
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 28(10): 917-e966, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339254
8.
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
Ann Surg Oncol
; 30(1): 395-403, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972667
9.
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
Ann Surg Oncol
; 30(11): 6558-6566, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368098
10.
Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals.
HPB (Oxford)
; 25(12): 1502-1512, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558565
11.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
Ann Surg Oncol
; 29(3): 1579-1591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724125
12.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Invest New Drugs
; 40(1): 134-141, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463891
13.
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
Dig Dis Sci
; 67(8): 3797-3805, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773565
14.
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
Ann Surg
; 273(2): 341-349, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946090
15.
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
Invest New Drugs
; 39(4): 1072-1080, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33646489
16.
Second-line therapies in advanced biliary tract cancers.
Lancet Oncol
; 21(1): e29-e41, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31908303
17.
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.
Oncologist
; 25(12): e1893-e1899, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776632
18.
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1681-e1690, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663355
19.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977
20.
A Novel Clinically Based Staging System for Gallbladder Cancer.
J Natl Compr Canc Netw
; 18(2): 151-159, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32023527